Afala

Afala tablets are shown:

• for the treatment of benign prostatic hyperplasia of the I and II stages;
• as part of complex therapy of acute and chronic prostatitis - as an anti-inflammatory and analgesic;
• with dysuric disorders (frequent urination, including at night, difficulty urinating, pain or discomfort in the perineum), including those accompanying benign prostatic hyperplasia of stage I and II;
• with acute and chronic prostatitis.

Structure

Active substances: 1 tablet contains antibodies to a prostate-specific antigen affinity-purified: a mixture of homeopathic dilutions C12, C30 and C200 - 0.003 g (3 mg);

Excipients: lactose, microcrystalline cellulose, magnesium stearate.

Contraindications

Increased individual sensitivity to the components of the drug.

Mode of application

Inside. At one time, 2 tablets (keep in the mouth until completely dissolved - not during meals). The drug is taken twice a day, in the evening and in the morning (before and after sleep). The recommended duration of the drug is 16 weeks.

With severe pain and dysuric disorders in the first 2 to 3 weeks of therapy, the drug is indicated up to 4 times a day.

If necessary, on the recommendation of a doctor, a second course of treatment is possible after 1 to 4 months.

Application features

Pregnancy

Not applicable to women.

Children

Contraindicated.

Drivers

Does not affect.

Overdose

In case of accidental overdose, dyspeptic phenomena are possible due to excipients that are part of the dosage form.

Side effects

When using the drug for the indicated indications and in the indicated dosages, no side effects were detected.

Interaction

Cases of incompatibility with other drugs have not yet been reported.

Storage conditions

Store at a temperature not exceeding 25 ° C, out of the reach of children.

Shelf life is 3 years.